Page 2 - Springworks News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Springworks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Springworks Today - Breaking & Trending Today

Bengaluru Start-up's CEO Gets 3K Resumes In 48 Hrs Without Posting JD, Asks 'How Bad Is Job Market?'

So bad is the situation that a start-up s CEO received three thousand job applications within a span of forty-eight hours. ....

Kartik Mandaville , Aditya Das , Vishudh Dhall , Arnav Gupta , Prashant Yadav Learnersbucket , Jasleen Arora Arorajasleen , Erwin Alberto , Aishit Jain Aishitjain , Founders Office , Bengaluru Start Up , Without Posting , How Bad Is Job , Growth Consultant , Miss Out , Start Up , Job Market , Mass Layoffs , Job Opening , Job Applications ,

Goldman Sachs Says Attractive Valuations Make Small-Cap Stocks Appealing; Here Are 2 'Strong Buy' Names With Solid Upside Potential

The S&P 500 is up by 14% year-to-date but it has not gone unnoticed that the robust performance has been driven by strong displays from the tech mega-caps. According to Goldman Sachs strategist Lily Calcagnini, there are better investment opportunities right now further down the food chain. “Small stocks trade at a valuation discount relative to large caps, suggesting now is an attractive entry point for investors with multi-year investing time horizons,” Calcagnini explained. “Even within the l ....

Corinne Jenkins , Lily Calcagnini , Madhu Kumar , Arvinas Inc , Goldman Sachs , Strong Buy , Springworks Therapeutics , Jenkin Buy , Best Stocks , Lily Calcagnini , Sp 500 , Springworks Therapeutics , Plexiform Neurofibroma , Ussell 2000 Index ,

SpringWorks Therapeutics : FDA Extends Review of Nirogacestat

By Colin Kellaher

SpringWorks Therapeutics on Monday said the U.S. Food and Drug Administration has extended its review of the company s application seeking approval of nirogacestat for adults. | June 5, 2023 ....

Colin Kellaher , Drug Administration , Works Therapeutics , Dow Jones , Springworks Therapeutics , Nc Stock Exchange , Press Release , Or Swtx Us85205l1070 ,

SpringWorks Therapeutics Announces Full Enrollment of Phase 2 Trial Evaluating Nirogacestat in Patients with Ovarian Granulosa Cell Tumors

STAMFORD, Conn., May 30, 2023 SpringWorks Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and. | May 30, 2023 ....

Saqib Islam , Samantha Hilson Sandler , National Cancer Institute , Dana Farber Cancer Institute , Fred Hutchinson Cancer Research Center , Drug Administration , European Commission , Springworks Therapeutics Inc , Works Therapeutics , Chief Executive Officer , Response Evaluation Criteria , Solid Tumors , New Drug Application , Time Oncology Review , Priority Review , Prescription Drug User Fee Act , Fast Track , Breakthrough Therapy Designations , Orphan Drug Designation , Private Securities Litigation Reform Act , Springwork Quarterly Report , Investor Relations , Hilson Sandler , Cancer Statistics , Springworks Therapeutics , Nc Stock Exchange ,

SpringWorks Therapeutics Announces Clinical Data Presentations of Nirogacestat in Combination with BCMA-Directed Therapies at the European Hematology Association 2023 Congress

STAMFORD, Conn., May 11, 2023 SpringWorks Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and. | May 11, 2023 ....

United States , Saqib Islam , Jim Cassidy , Samantha Hilson Sandler , Dana Farber Cancer Institute , Drug Administration , Janssen Research Development , American Society Of Clinical Oncology , Fred Hutchinson Cancer Research Center , European Hematology Association , Springworks Therapeutics Inc , European Commission , Works Therapeutics , Janssen Research , Chief Executive Officer , Clinical Oncology , Chief Medical Officer , New Drug Application , Time Oncology Review , Priority Review , Prescription Drug User Fee Act , Fast Track , Breakthrough Therapy Designations , Orphan Drug Designation , Private Securities Litigation Reform Act , Springwork Quarterly Report ,